Interventions for preventing infection in nephrotic syndrome

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 10, 2012, Pages

  Wu, Hong Mei ^a   Tang, Jin Ling ^b   Cao, Li ^a   Sha, Zhao Hui ^c   Li, Youping ^a  

^a SICHUAN UNIVERSITY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LYSATE; BCG VACCINE; CHINESE DRUG; IMMUNOGLOBULIN; MANNAN; PNEUMOCOCCUS VACCINE; THYMOSIN; TRANSFER FACTOR; HERBACEOUS AGENT; HUANG QI;

ASTRAGALUS (PLANT); CHEMOPROPHYLAXIS; CHINA; CHINESE HERB; COUGHING; DISEASE ASSESSMENT; DYSPNEA; FEVER; HUMAN; INFECTION; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; INFORMATION PROCESSING; INTRAVENOUS DRUG ADMINISTRATION; MORTALITY RATE; NEPHROTIC SYNDROME; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPHYLAXIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGISTER; REVIEW; RHINOSCLEROMA; RISK REDUCTION; SIDE EFFECT; SYSTEMATIC REVIEW; TACHYCARDIA; ASTRAGALUS PLANT; BACTERIAL INFECTION; CHILD; CROSS INFECTION; META ANALYSIS;

ASTRAGALUS PLANT; BACTERIAL INFECTIONS; BCG VACCINE; CHILD; CHINA; CROSS INFECTION; DRUGS, CHINESE HERBAL; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; NEPHROTIC SYNDROME; RANDOMIZED CONTROLLED TRIALS AS TOPIC; THYMOSIN; TRANSFER FACTOR;

EID: 84864042669     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003964.pub3     Document Type: Review

References (61)

1. Chen J, Chen SQ. Preventive effects of Huangqi on infection in children with nephrotic syndrome. Zhong Guo Zhong Xi Yi Jie He Za Zhi [Chinese Journal of Integrated Traditional and Western Medicine] 2008;28(5):467-9.
2. Dang X, Yi Z, Wang X, Wu X, Zhang X, He Q. Preventive efficiency of IVIgG on nosocomial infection in the children with nephrotic syndrome. Bulletin of Hunan Medical University 1999;24(3):290-2. [MEDLINE: 12016811]
3. Dou ZY, Wang JY, Liu YP. Preventive efficiency of low-dose IVIgG on infection in nephrotic syndrome. Chinese Journal of Biologicals 2000;13(3):160.
4. Guo YC, Cheng YY, Zhang LH. Preventive effects of secondary Infection on children simple nephrotic syndrome by mannan peptide. Chinese JournaI of MedicinaI Guide 2008;10(5):715-6.
5. Kang GG. Preventive effect of complicated infection of children with nephrotic syndrome on vaccine injection. Chinese Pediatric Emergency Medicine 2003;10(5):299-301.
6. Kang GG. Preventive effects of Huangqi on secondary infection in children with simple nephrotic syndrome. Chinese Journal of Integrated Traditional and Western Nephrology 2005;6(12):718-9.
7. Li RH, Peng ZP, Wei YL, Liu CH. Clinical observation on Chinese medicinal herbs combined with prednisone for reducing the risks of infection in children with nephrotic syndrome. Information Journal of Chinese Medicine 2000;7(10):60-1.
8. Rao XZ. Preventive effect of oral transferin factor on secondary infection in children with simple nephrotic syndrome. Chinese Journal of Coal Industry Medicine 2005;8(3):270.
9. Tong LZ, Mi LZ. Preventive efficiency of IVIgG on secondary nosocomial infection in nephrotic syndrome. Modern Rehabilitation 1998;2(3):236.
10. Wu QY, Wu X. Clinical study of gammaglobulin on upper respiratory infection prevention in nephrotic syndrome children. Journal of Hainan Medical College 2009;15(8):879-80.
11. Ye QB, Huang T, Li ZH, Wang YQ. The clinical research on using polyvalent bacterial vaccine to prevent the nosocomial infection of children with primary nephritic syndrome. Applied Journal of General Practice 2004;12(2):132-4.
12. Zhang YJ, Wang Y, Yang ZW, Li XT. Thymosin for the prevention of infection in children with the idiopathic nephrotic syndrome. Chinese Journal of Contemporary Pediatrics 2000;2(3):197-9.
13. Abeyagunawardena AS, Trompeter RS. Increasing the dose of prednisolone during viral infections reduces the risk of relapse in nephrotic syndrome: a randomised controlled trial. Archives of Disease in Childhood 2008;93(3):226-8. [MEDLINE: 17573408]
14. Allison AC, Hendrickse RG, Edington GM, Houba V, De Petris S, Adeniyi A. Immune complexes in the nephrotic syndrome of African children. Lancet 1969;1(7608):1232-8. [MEDLINE: 4182413]
15. Goldstein SL, Somers MJ, Lande MB, Brewer ED, Jabs KL. Acyclovir prophylaxis of varicella in children with renal disease receiving steroids. Pediatric Nephrology 2000;14(4):305-8. [MEDLINE: 10775074]
16. Grzesiowski P, Tanska A, Sieniawska M. The influence of hepatitis B vaccine dose on direct results of hepatitis B vaccination in children with nephrotic syndrome. Pediatria Polska 1995;70(1):25-8. [EMBASE: 1995078155]
17. Abeyagunawardena AS, Goldblatt D, Andrews N, Trompeter RS. Risk of relapse after meningococcal C conjugate vaccine in nephrotic syndrome. Lancet 2003;362(9382):449-50. [MEDLINE: 12927434]
18. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 1996;276(8):637-9. [MEDLINE: 8773637]
19. Brodehl J. Nephrotic syndrome in children: diagnosis and treatment. World Pediatrics and Child Care 1986;1:9-18.
20. Chan HL, Tang JL, Tam W, Sung JJ. The efficacy of thymosin in the treatment of chronic hepatitis B virus infection: a meta-analysis. Alimentary Pharmacology & Therapeutics 2001;15(12):1899-905. [MEDLINE: 11736720]
21. Choudhary VP, Ghai OP. Peritonitis in nephrotic syndrome. Indian Pediatrics 1977;14(5):405-8. [MEDLINE: 924655]
22. Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. BMJ 1994;309(6964):1286-91. [MEDLINE: 7718048]
23. Du PF, Zhu SR, Wang GP. An analysis for nosocomial infection in primary nephrotic syndrome- a report of 125 cases. Chinese Journal of Clinical Pediatrics 1996;14(1):35-6.
24. Eddy AA, Symons JM. Nephrotic syndrome in childhood. Lancet 2003;362(9384):629-39. [MEDLINE: 12944064]
25. Furth SL, Arbus GS, Hogg R, Tarver J, Chan C, Fivush BA, et al. Varicella vaccination in children with nephrotic syndrome: a report of the Southwest Pediatric Nephrology Study Group. Journal of Pediatrics 2003;142(2):145-8. [MEDLINE: 12584535]
26. Gaston MH, Verter JI, Woods G, Pegelow C, Kelleher J, Presbury G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. New England Journal of Medicine 1988;314(25):1593-9. [MEDLINE: 3086721]
27. Gulati S, Kher V, Arora P, Gupta S, Kale S. Urinary tract infection in nephrotic syndrome. Pediatric Infectious Disease Journal 1996;15(3):237-40. [MEDLINE: 8852912]
28. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60. [MEDLINE: 12958120]
29. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
30. Anonymous. Minimal change nephrotic syndrome in children: deaths during the first 5-15 years observation. Report of the international Study of Kidney Disease in Children. Pediatrics 1984;73(4):497-501. [MEDLINE: 6709428]
31. Jiang X. The revised suggestions on clinical classifications and treatments for glomerular diseases in children. Journal of Chinese Pediatrics 1981;19:241-3.
32. Johnson RJ, Feehally J. Introduction to glomerular disease: clinical presentations. Comprehensive Clinical Nephrology. London: Mosby, 2000. [ISBN: 0723431175]
33. Kjaergard LL, Villumsen J, Gluud C. Quality of randomised clinical trials affects estimates of intervention efficacy. Seventh International Cochrane Colloquium; 1999 Oct; Rome (Italy). 1999:57.
34. Lefebvre C, McDonald S. Development of a sensitive search strategy for reports of randomized controlled trials in EMBASE. Fourth International Cochrane Colloquium; 1996 Oct 20-24; Adelaide (Australia). 1996.
35. Li YK, Jiang MY. Pharmacology of Traditional Chinese Medicine. Beijing: China Press of Traditional Chinese Medicine, 1992.
36. Li YJ, Xie C, Xia ZM. Risk factors for infection in adult nephrotic syndrome. Chinese Journal of Nephrology 1996;12(2):76-8.
37. Liang M. The clinical application of intravenous immunoglobulin gamma. Practical Journal of Chinese Pediatrics 1994;9(5):265-7.
38. Ma YW, Yuan XY, Jiang JY. Nosocomial infection and nephrotic syndrome in children. Chinese Journal of Nosocomiology 1996;6(1):12-4.
39. Knezevic-Maramica I, Kruskall MS. Intravenous immune globulins: an update for clinicians. Transfusion 2003;43(10):1460-80. [MEDLINE: 14507280]
40. McIntyre P, Craig JC. Prevention of serious bacterial infection in children with nephrotic syndrome. Journal of Paediatrics & Child Health 1998;34(4):314-7. [MEDLINE: 9727168]
41. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet 1998;352(9128):609-13. [MEDLINE: 9746022]
42. Moorani KN, Khan KM, Ramzan A. Infections in children with nephrotic syndrome. Jcpsp, Journal of the College of Physicians & Surgeons - Pakistan 2003;13(6):337-9. [MEDLINE: 12814532]
43. Napodano RJ. Values in Medical Practice. New York, NY: Human Sciences Press, 1986.
44. Ogi M, Yokoyama H, Tomosugi N, Hisada Y, Ohta S, Takaeda M, et al. Risk factors for infection and immunoglobulin replacement therapy in adult nephrotic syndrome. American Journal of Kidney Diseases 1994;24(3):427-36. [MEDLINE: 8079968]
45. Pozzi E, Serra C. Efficacy of Lantigen B in the prevention of bacterial respiratory infections. Monaldi Archives for Chest Disease 2004;61(1):19-27. [MEDLINE: 15366332]
46. Roth KS, Amaker BH, Chan JC. Nephrotic syndrome: pathogenesis and management. Pediatrics in Review 2002;23(7):237-48. [MEDLINE: 12093934]
47. Schnaper HW. Immunization practices in childhood nephrotic syndrome: a survey of North American pediatric nephrologists. Pediatric Nephrology 1994;8(1):4-6. [MEDLINE: 8142223]
48. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408-12. [MEDLINE: 7823387]
49. Shroff A, Frank R, Vergara M, Gauthier B, Trachtman H. Prevention of serious bacterial infections in new-onset nephrotic syndrome: a survey of current practices. Clinical Pediatrics 2002;41(1):47-9. [MEDLINE: 11866366]
50. Tain YL, Lin G, Cher TW. Microbiological spectrum of septicemia and peritonitis in nephrotic children. Pediatric Nephrology 1999;13(9):835-7. [MEDLINE: 10603131]
51. Tomlinson B, Chan TY, Chan JC, Critchley JA, But PP. Toxicity of complementary therapies: an eastern perspective. Journal of Clinical Pharmacology 2000;40(5):451-6. [MEDLINE: 10806596]
52. Ulinski T, Leroy S, Dubrel M, Danon S, Bensman A. High serological response to pneumococcal vaccine in nephrotic children at disease onset on high-dose prednisone. Pediatric Nephrology 2008;23(7):1107-13. [MEDLINE: 18324419]
53. Vickers A, Goyal N, Harland R, Rees R. Do certain countries produce only positive results? A systematic review of controlled trials. Controlled Clinical Trials 1998;19(2):159-66. [MEDLINE: 9551280]
54. Wang SQ, Zhang BY. Nosocomiology. Chongqing: Science Technological Publishing House, 1990.
55. Wang K, Chui AD. An analysis of dangerous factors for relapse in primary nephrotic syndrome. Acta Academiae Medicine XuZhou 1999;19(3):227-8.
56. Wu LY, Dan XQ. An analysis of risk factors and managements for nosocomial infection in children with nephrotic syndrome. Chinese Journal of Nosocomiology 1998;8(B):34-5.
57. Wu B, Xu NF, Yang LP, Chen SQ. Clinical epidemiology study on risk factors for nosocomial infection in children with nephrotic syndrome. Chinese Journal of Nosocomiology 2000;10(3):171-3.
58. Xu XY. Pharmacology of Traditional Chinese Medicine. Beijing: China Press of Traditional Chinese Medicine, 2010.
59. Yap HK, Han EJ, Heng CK, Gong WK. Risk factors for steroid dependency in children with idiopathic nephrotic syndrome. Pediatric Nephrology 2001;16(12):1049-52. [MEDLINE: 11793098]
60. Wu HM, Tang JL, Sha ZH, Li YP. Interventions for preventing infection in nephrotic syndrome. Cochrane Database of Systematic Reviews 2003, Issue 1. [DOI: 10.1002/14651858.CD003964]
61. Wu HM, Tang JL, Sha ZH, Li Y, Cao I. Interventions for preventing infection in nephrotic syndrome. Cochrane Database of Systematic Reviews 2004, Issue 2. [DOI: 10.1002/14651858.CD003964.pub2]